|Articles|March 9, 2023
Importance of Data Reproducibility for Development of Safe Gene Therapies
Author(s)Thermo Fisher
In this application note you will learn the importance of reproducible gene expression quantitation to evaluate host immune response for optimizing safety of gene therapies.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Amgen’s Tarlatamab Approved in China
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
4
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
5